Relations of Genetic Variants in Superoxide Dismutase 2 and Dystrobrevin-binding Protein 1 to Methamphetamine Psychosis among Methamphetamine Dependents in Taiwan

10.4103/TPSY.TPSY_23_19

Ying-Ching Lai；Shih-Ku Lin；Ming-Chyi Huang；Hsing-Cheng Liu；Yen-Lung Chiou；Chun-Hsin Chen；Wei J. Chen

oxidative stress ； polymorphism ； reactive oxygen species ； scavenger

台灣精神醫學

33卷2期（2019 / 06 / 01）

83 - 91

英文

Objectives: Both superoxide dismutase 2 gene (SOD2), encoding a free radical scavenger, and dystrobrevin-binding protein 1 gene (DTNBP1), a candidate gene for schizophrenia, have been implicated in methamphetamine (METH) psychosis. In this study, we intended to compare the distribution of those two genes between METH users with and without psychosis and to evaluate whether the length of time of METH exposure influenced such relationship. Methods: The study sample consisted of 84 cases of patients with METH-induced psychosis and 187 controls (METH users without psychosis). Five single-nucleotide polymorphisms (SNPs) in SOD2 and three SNPs in DTNBP1 were genotyped. We did both single-locus and haplotype analyses, and adjusted for multiple comparisons with an effective number of markers, and multivariable logistic regression analyses for adjusting for age, sex, and duration of METH use. Results: None of the individual SNPs were associated with METH-induced psychosis after adjustment for multiple comparisons. In the subgroup analysis, both rs4880 and rs2855116 in SOD2 were significantly associated with prolonged METH-induced psychosis (p ＜ 0.01 and p ＜ 0.01, respectively). Under the assumption of a codominant model, the CC genotype of rs4880 was significantly associated with METH-induced psychosis after adjustments for age, sex, and the duration of METH use (p ＜ 0.01). This association was not supported by the haplotype analyses or gene-gene interactions between SOD2 and DTNBP1. Conclusion: Functional C-allele of rs4880 in SOD2 was associated with the prolonged subtype of METH-induced psychosis in Taiwanese population. Oxidative stress mechanisms show a rôle in the development of METH-induced psychosis.

1. Barrett, JC,Fry, B,Maller, J(2005).Haploview: analysis and visualization of LD and haplotype maps.Bioinformatics,21,263-265.
2. Bousman, CA,Glatt, SJ,Everall, IP(2009).Genetic association studies of methamphetamine use disorders: a systematic review and synthesis.Am J Med Genet B Neuropsychiatr Genet,150B,1025-1049.
3. Cadet, JL,Brannock, C(1998).Free radicals and the pathobiology of brain dopamine systems.Neurochem Int,32,117-131.
4. Cadet, JL,Sheng, P,Ali, S(1994).Attenuation of methamphetamineinduced neurotoxicity in copper/zinc superoxide dismutase transgenic mice.J Neurochem,62,380-383.
5. Chandramani Shivalingappa, P,Jin, H,Anantharam, V(2012).N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells.Parkinsons Dis,2012,424285.
6. Chen, CK,Lin, SK,Sham, PC(2003).Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.Psychol Med,33,1407-1414.
7. Chen, HM,Lee, YC,Huang, CL(2007).Methamphetamine downregulates peroxiredoxins in rat pheochromocytoma cells.Biochem Biophys Res Commun,354,96-101.
8. Chen, WJ,Liu, SK,Chang, CJ(1998).Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.Am J Psychiatry,155,1214-1220.
9. Chen, WJ,Wu, SC,Tsay, WI(2017).Differences in prevalence, sociobehavioral correlates, and psychosocial distress between club drug and hard drug use in Taiwan: results from the 2014 national survey of substance use.Int J Drug Policy,48,99-107.
10. Chen, YC,Giovannucci, E,Lazarus, R(2005).Sequence variants of tolllike receptor 4 and susceptibility to prostate cancer.Cancer Res,65,11771-11778.
11. Chiang, SC,Chen, CY,Chang, YY(2007).Prevalence of heroin and methamphetamine male users in the Northern Taiwan, 1999-2002: capture-recapture estimates.BMC Public Health,7,292.
12. Choi, HJ,Yoo, TM,Chung, SY(2002).Methamphetamine-induced apoptosis in a CNS-derived catecholaminergic cell line.Mol Cells,13,221-227.
13. Gabriel, SB,Schaffner, SF,Nguyen, H(2002).The structure of haplotype blocks in the human genome.Science,296,2225-2229.
14. Harrison, PJ,Weinberger, DR(2005).Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.Mol Psychiatry,10,40-68.
15. Kishimoto M,Ujike, H,Motohashi, Y(2008).The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.Biol Psychiatry,63,191-196.
16. Kittirattanapaiboon, P,Mahatnirunkul, S,Booncharoen, H(2010).Longterm outcomes in methamphetamine psychosis patients after first hospitalisation.Drug Alcohol Rev,29,456-461.
17. Liu, CM,Liu, YL,Fann, CS(2007).No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families.Schizophr Res,93,391-398.
18. Lou, XY,Chen, GB,Yan, L(2007).A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence.Am J Hum Genet,80,1125-1137.
19. McKetin, R,Hickey, K,Devlin, K(2010).The risk of psychotic symptoms associated with recreational methamphetamine use.Drug Alcohol Rev,29,358-363.
20. McKetin, R,Lubman, DI,Baker, AL(2013).Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.JAMA Psychiatry,70,319-324.
21. McKetin, R,McLaren, J,Lubman, DI(2006).The prevalence of psychotic symptoms among methamphetamine users.Addiction,101,1473-1478.
22. Nakamura, K,Chen, CK,Sekine, Y(2006).Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.Hum Genet,120,243-252.
23. Nelson, SK,Bose, SK,McCord, JM(1994).The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart.Free Radic Biol Med,16,195-200.
24. Nyholt, DR(2004).A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.Am J Hum Genet,74,765-769.
25. Pubill, D,Chipana, C,Camins, A(2005).Free radical production induced by methamphetamine in rat striatal synaptosomes.Toxicol Appl Pharmacol,204,57-68.
26. Raybould, R,Green, EK,MacGregor, S(2005).Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1).Biol Psychiatry,57,696-701.
27. Salo, R,Flower, K,Kielstein, A(2011).Psychiatric comorbidity in methamphetamine dependence.Psychiatry Res,186,356-361.
28. Seger, D(2010).Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.Clin Toxicol (Phila),48,695-708.
29. Sommers, I,Baskin, D,Baskin-Sommers, A(2006).Methamphetamine use among young adults: health and social consequences.Addict Behav,31,1469-1476.
30. Sutton, A,Khoury, H,Prip-Buus, C(2003).The ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria.Pharmacogenetics,13,145-157.
31. Tregouet, DA,Garelle, V(2007).A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies.Bioinformatics,23,1038-1039.
32. Tsuang, MT,Bar, JL,Harley, RM(2001).The Harvard twin study of substance abuse: what we have learned.Harv Rev Psychiatry,9,267-279.
33. United Nations Office on Drugs and Crime(2018).World Drug Report 2018. 2. Global Overview of Drug Demand and Supply: Latest Trends and Cross-Cutting Issues.Vienna:United Nations Office on Drugs and Crime.
34. Volz, TJ,Fleckenstein, AE,Hanson, GR(2007).Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.Addiction,102(Suppl 1),44-48.
35. Wiener, HW,Perry, RT,Chen, Z(2007).A polymorphism in SOD2 is associated with development of Alzheimer’s disease.Genes Brain Behav,6,770-775.
36. Williams, NM,Preece, A,Morris, DW(2004).Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).Arch Gen Psychiatry,61,336-344.
37. Wispé, JR,Clark, JC,Burhans, MS(1989).Synthesis and processing of the precursor for human mangano-superoxide dismutase.Biochim Biophys Acta,994,30-36.
38. Wu, CW,Ping, YH,Yen, JC(2007).Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis.Toxicol Appl Pharmacol,220,243-251.
39. Xu, Z,Zhu, H,Luk, JM(2012).Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.Cancer,118,5489-5496.
40. Yao, S,Barlow, WE,Albain, KS(2010).Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.Breast Cancer Res Treat,124,433-439.